MAP3K14 Knockout Cell Line - CD BioSciences

service-banner

MAP3K14 Knockout Cell Line

MAP3K14 Knockout Cell Line

SPL-01987

Size Price
1 Unit Online Inquiry
Description
29bp deletion
Target Information
Target Name NIK
Gene Abbr. MAP3K14
Gene ID 9020
Full Name mitogen-activated protein kinase kinase kinase 14
Alias FTDCR1B, HS, HSNIK, NIK
Species Human
Genomic Locus chr17:45290499
Transcript NM_003954
WT Expression Level 1.30 TPM (TPM = Transcripts per million; any value less than 3 is considered non-expressing)
Introduction This gene encodes mitogen-activated protein kinase kinase kinase 14, which is a serine/threonine protein-kinase. This kinase binds to TRAF2 and stimulates NF-kappaB activity. It shares sequence similarity with several other MAPKK kinases. It participates in an NF-kappaB-inducing signalling cascade common to receptors of the tumour-necrosis/nerve-growth factor (TNF/NGF) family and to the interleukin-1 type-I receptor. [provided by RefSeq, Jul 2008].
Product Details
Cell Line Model HAP1
Genotype HAP1 cell line, edited by CRISPR/Cas to contain a 29bp deletion in a coding exon of MAP3K14.
Description 29bp deletion
Parental Cell Line C631
Guide RNA Sequence TGCCATCTCTATCATCGCCC
PCR Primer Forward: TGTAAAACGACGGCCAGTCAGGATGAGCACAAGCCTG
Reverse: TACCTCTCTTCCCCTGCTCC
Handling Specifications
Revival Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into 10 mL of pre-warmed media in a 10 cm dish.
Culture Medium IMDM + 10% FCS
Growth Properties Cells are adherent cells that are cultured at 37°C in a humidified atmosphere with 5% CO2. Cells should be passaged every 2-3 days, splitting approximately 1:10-1:20.
Freeze Medium IMDM + 20% FCS + 10% DMSO
Biosafety Level BSL-1
Disclaimer This product is classified under IATA regulations as a GMMO (genetically modified micro-organism) and will ship as UN3245. If applicable, ensure facility meets all requirements per local and country regulations.

For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.